Dr Angela Devine
Post-doctoral health scientist
PhD, The Open University, 2018; Master of Science, London School of Hygiene and Tropical Medicine, 2008; Bachelor of Science, University of Evansville, 2006
Angela Devine is a health economist with 10 years of experience in economic evaluation and costing. She is currently based in the Centre for Epidemiology and Biostatistics at the University of Melbourne where she has an honorary position.
Her current research is focused on the burden of disease and cost-effectiveness of options for the management of vivax malaria. In particular, she investigates options for improving the safe and effective deployment of primaquine in a variety of transmission and geographical settings in order to optimise a global strategy for the radical cure of vivax malaria.
Her previous work has addressed a variety of topics, including the impact of early antiretroviral therapy for individuals with HIV and hepatitis B co-infections, strategies for cervical cancer screening in HIV clinics in Africa and modelling the long-term impact of an identification and referral programme for intimate partner violence.
Her methodological research interests include capturing the joint costs and effects of co-infections and the cost-effectiveness of malaria control options in elimination settings.
- Improving the radical cure of vivax malaria (IMPROV)
- Optimizing the radical cure of P.vivax malaria (OPRA)
- Devine, A., Kenangalem, E., Burdam, F. H., Anstey, N. M., Poespoprodjo, J. R., Price, R. N., et al. (2018). Treatment-Seeking Behavior after the Implementation of a Unified Policy of Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Malaria in Papua, Indonesia. American Journal of Tropical Medicine and Hygiene, 98(2), 543-550.
- Devine, A., Harvey, R., Min, A. M., Gilder, M. E. T., Paw, M. K., Kang, J., et al. (2017). Strategies for the prevention of perinatal hepatitis B transmission in a marginalized population on the Thailand-Myanmar border: a cost-effectiveness analysis. BMC Infectious Diseases, 17(1), 552.
- Devine, A., Parmiter, M., Chu, C. S., Bancone, G., Nosten, F., Price, R. N., et al. (2017). Using G6PD tests to enable the safe treatment of Plasmodium vivax infections with primaquine on the Thailand-Myanmar border: A cost-effectiveness analysis. PLoS Neglected Tropical Diseases, 11(5), e0005602.
- Drake, T. L., Lubell, Y., Kyaw, S. S., Devine, A., Kyaw, M. P., Day, N. P., et al. (2017). Geographic Resource Allocation Based on Cost Effectiveness: An Application to Malaria Policy. Appl Health Econ Health Policy, 15(3), 299-306.
- Karyana, M., Devine, A., Kenangalem, E., Burdarm, L., Poespoprodjo, J. R., Vemuri, R., et al. (2016). Treatment-seeking behaviour and associated costs for malaria in Papua, Indonesia. Malaria Journal, 15(1), 536.
- Drake, T. L., Devine, A., Yeung, S., Day, N. P., White, L. J., & Lubell, Y. (2016). Dynamic Transmission Economic Evaluation of Infectious Disease Interventions in Low- and Middle-Income Countries: A Systematic Literature Review. Health Economics, 25 Suppl 1, 124-139.
- Devine, A., Taylor, S. J., Spencer, A., Diaz-Ordaz, K., Eldridge, S., & Underwood, M. (2014). The agreement between proxy and self-completed EQ-5D for care home residents was better for index scores than individual domains. Journal of Clinical Epidemiology, 67(9), 1035-1043.
- Martin, N. K., Devine, A., Eaton, J. W., Miners, A., Hallett, T. B., Foster, G. R., et al. (2014). Modeling the impact of early antiretroviral therapy for adults coinfected with HIV and hepatitis B or C in South Africa. AIDS, 28 Suppl 1, S35-46.
- Underwood, M., Lamb, S. E., Eldridge, S., Sheehan, B., Slowther, A. M., Spencer, A., et al. (2013). Exercise for depression in elderly residents of care homes: a cluster-randomised controlled trial. Lancet, 382(9886), 41-49.
- Devine, A., Spencer, A., Eldridge, S., Norman, R., & Feder, G. (2012). Cost-effectiveness of Identification and Referral to Improve Safety (IRIS), a domestic violence training and support programme for primary care: a modelling study based on a randomised controlled trial. BMJ Open, 2(3), pii: e001008.